YOKNEAM, Israel, May 8 /PRNewswire/ -- DeepFX and ActiveFX were featured during this year's annual meeting of The American Society of Aesthetic Plastic Surgery (ASAPS) in San Diego during the Cosmetic Medicine course, chaired by Jeffrey Kenkel, MD of UTSW.
Dr. Kenkel has been using the fractional ActiveFX technology for more than two years, and commented about Lumenis' latest technological advancement. "I'm excited about this new generation of CO2 devices because I can offer my patients a single treatment that provides desired results with manageable downtime," Dr. Kenkel said.
Michael Kulick, MD, of San Francisco showcased DeepFX at the full-day course. Dr. Kulick performed a live DeepFX treatment, answering audience questions regarding pre- and post-treatment protocols, depth of penetration, and optimal settings. He noted that his patient felt little to no discomfort with the treatment, and had less post-operative side effects than other fractional devices that were presented.
Deep FX, the latest in fractional treatment offered by Lumenis Inc., joins the already popular ActiveFX as a powerful way to treat wrinkles, scars, skin tone and texture in a single treatment with minimum downtime.
ActiveFX targets the epidermal and papillary dermal layers of the skin and is ideal for treating conditions that manifest in the upper layers of the skin, including fine lines, dyschromia, and textural irregularities. DeepFX, which was introduced in 2007, targets the deep dermal layers of the skin, and provides exceptional results on deep wrinkles, scars, and peri-oral rhytids.
"The UltraPulse Encore, is the only system with both DeepFX and
ActiveFX resurfacing options, providing physicians the most versatile CO2
laser in the industry" commented Dale Koop, Sr. Vice President and head of
Lumenis' Strategic Aesthetic Business Unit. "Long known as the 'gold
standard' in the industry, the UltraPulse Encore is a shining example of
|SOURCE Lumenis Ltd.|
Copyright©2008 PR Newswire.
All rights reserved